Skip to main content
BRBR
NYSE Manufacturing

BellRing Q3 Sales Rise 4% but EBITDA Crashes 35% on Inventory Charges; Litigation Settlements Loom

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$12.18
Mkt Cap
$1.416B
52W Low
$7.82
52W High
$54.65
52W Position info
56% above low
Off High info
78% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

BRBR sits 56% above its 52-week low of $7.82.

Summary

BellRing Brands reported Q3 net sales of $570.4M (+4% YoY), but Adjusted EBITDA plunged 35% to $78.3M on inventory charges and higher costs. Cash flow weakened, debt rose, and $88M in litigation settlement payments are due within days.


Key Events · Earnings and Guidance · BRBR

  • Q3 Sales Up, Profitability Down

    Net sales rose 4% to $570.4M, but Adjusted EBITDA fell 35% to $78.3M. Gross margin compressed to 28.6% from 35.4% a year ago, driven by a $10M inventory reserve and higher input costs.

  • Inventory Surge and Cash Flow Strain

    Finished goods inventory ballooned to $409.9M from $242.0M at fiscal year-end, contributing to a $150.7M inventory build. Operating cash flow dropped to $65.0M from $91.5M in the prior year period.

  • Litigation Settlements Due Within Days

    The Joint Juice class action settlements require $88.0M in payments by August 10, 2026 ($17.2M for New York, $68.8M for multistate). The securities class action motion to dismiss was partially denied on July 28, 2026.

  • Debt and Liquidity

    Revolving credit facility borrowings increased to $300.0M from $250.0M at fiscal year-end, with $197.6M remaining available. Total debt stands at $1.14B against a stockholders' deficit of $467.2M.


Analysis · BRBR · Manufacturing

BellRing's Q3 results reveal a stark divergence: while the top line grew 4% to $570.4M, profitability was crushed by a 35% plunge in Adjusted EBITDA to $78.3M. The damage stems from a massive inventory build—finished goods inventory nearly doubled from fiscal year-end to $409.9M—and a $10M inventory reserve charge, compounded by higher raw material and freight costs. Operating cash flow weakened to $65M from $91.5M a year ago, and the company drew an additional $50M on its revolver, bringing the balance to $300M. On the legal front, the long-running Joint Juice class action is nearing resolution with $88M in settlement payments due by August 10, 2026, while the securities class action survived a partial motion to dismiss. Meanwhile, aggressive buybacks continue: $134.5M worth of stock was repurchased at an average $27.41, well above today's $12.18 price, raising questions about capital allocation priorities given the cash needs for litigation settlements.

At the time of this filing, BRBR was trading at $12.18 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $7.82 to $54.65. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BRBR - Latest Insights

BRBR
Aug 04, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
7
BRBR
Aug 04, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
BRBR
Jul 08, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
8
BRBR
Jun 24, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
7
BRBR
May 05, 2026, 10:21 AM EDT
Filing Type: 10-Q
Importance Score:
9